Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia (SeluDex)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03705507
Recruitment Status : Recruiting
First Posted : October 15, 2018
Last Update Posted : November 22, 2019
Cancer Research UK
Information provided by (Responsible Party):
University of Birmingham

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 17, 2020
Estimated Study Completion Date : December 17, 2020